Evidence Hub

The Effect of Anticholinergics on Cognitive Function in the Elderly: a Randomized Controlled Trial

ClinicalTrials.gov · COMPLETED, 2015

59 participants

Abstract

Anticholinergic medication is used to treat overactive bladder (OAB). A known side effect of this medication is cognitive dysfunction. OAB is more prevalent in the elderly population - a group that also has a higher baseline risk of cognitive dysfunction. Our objective is to evaluate the effect of an anticholinergic medication on cognitive function in elderly women.

Conditions: Mental Competency, Urinary Bladder, Overactive, Cognitive Function.

Primary outcome: Hopkins Verbal Learning Test - Revised; Hopkins Verbal Learning Test - Revised.

Enrollment: 59 participants.

How strong is the evidence?

Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 59 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free